Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA clears 2 HeartFlow solutions | The next generation of cholesterol-lowering agents | Valentin Fuster's new role
Wednesday, October 19, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

HeartFlow gains FDA clearance for 2 new AI-powered imaging assessments

The solutions, Plaque Analysis and RoadMap Analysis, both use coronary CT angiography to provide clinicians with a noninvasive look at patients who present with coronary artery disease and face a heightened myocardial infarction risk.

READ MORE >
Left, HeartFlow's RoadMap analysis enables cardiac CT readers to identify stenoses in the major coronary arteries. The AI provides visualization and quantification of the location and severity of anatomic narrowings. Right image, HeartFlow's Plaque Analysis AI algorithm automates assessment of coronary plaque characteristics and volume on CCTA exams to greatly reduce the time it takes to manually assess and quantify these features.
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow gains FDA clearance for 2 new AI-powered imaging assessments

Share on Twitter Share on Facebook Share on Linkedin
Left, HeartFlow's RoadMap analysis enables cardiac CT readers to identify stenoses in the major coronary arteries. The AI provides visualization and quantification of the location and severity of anatomic narrowings. Right image, HeartFlow's Plaque Analysis AI algorithm automates assessment of coronary plaque characteristics and volume on CCTA exams to greatly reduce the time it takes to manually assess and quantify these features.
The solutions, Plaque Analysis and RoadMap Analysis, both use coronary CT angiography to provide clinicians with a noninvasive look at patients who present with coronary artery disease and face a heightened myocardial infarction risk.
READ MORE >

VIDEO: Deepak Bhatt discusses the role of new cholesterol-lowering agents

Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care. 

READ MORE >
Deepak Bhatt, MD, MPH, executive director of the interventional cardiovascular programs at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, explained the new generation of cholesterol lowering agents and their roles in various types of patients.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Deepak Bhatt discusses the role of new cholesterol-lowering agents

Share on Twitter Share on Facebook Share on Linkedin
Deepak Bhatt, MD, MPH, executive director of the interventional cardiovascular programs at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, explained the new generation of cholesterol lowering agents and their roles in various types of patients.
Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care. 
READ MORE >

Cardiologist Valentin Fuster named president of Mount Sinai Heart

The hugely influential doctor will still serve as the general director of the Spanish National Center for Cardiovascular Research and editor-in-chief of the Journal of the American College of Cardiology.

READ MORE >
Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist Valentin Fuster named president of Mount Sinai Heart

Share on Twitter Share on Facebook Share on Linkedin
Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research.
The hugely influential doctor will still serve as the general director of the Spanish National Center for Cardiovascular Research and editor-in-chief of the Journal of the American College of Cardiology.
READ MORE >

Apixaban outperforms rivaroxaban when treating patients with AFib and valvular heart disease

Researchers explored data from nearly 20,000 patients, sharing their findings in Annals of Internal Medicine.

READ MORE >
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Share on Twitter Share on Facebook Share on Linkedin

Apixaban outperforms rivaroxaban when treating patients with AFib and valvular heart disease

Share on Twitter Share on Facebook Share on Linkedin
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Researchers explored data from nearly 20,000 patients, sharing their findings in Annals of Internal Medicine.
READ MORE >

Featured Articles

Transcarotid TAVR a safe alternative when femoral access is not an option

The conventional transfemoral approach is not always possible during TAVR procedures, leaving care teams with an important decision to make. 

READ MORE >
transcarotid TAVR TAVI transcatheter aortic valve replacement
Share on Twitter Share on Facebook Share on Linkedin

Transcarotid TAVR a safe alternative when femoral access is not an option

Share on Twitter Share on Facebook Share on Linkedin
transcarotid TAVR TAVI transcatheter aortic valve replacement
The conventional transfemoral approach is not always possible during TAVR procedures, leaving care teams with an important decision to make. 
READ MORE >

‘He will be deeply missed’: Veteran cardiologist, dead at 76, remembered for his kindness and devotion

Asher Kimchi, MD, a veteran cardiologist with Cedars-Sinai Medical Center in Los Angeles, died on Oct. 7. His friends and colleagues shared loving tributes to his legacy. 

READ MORE >
Asher Kimchi, MD. Image courtesy of Cedars-Sinai.
Share on Twitter Share on Facebook Share on Linkedin

‘He will be deeply missed’: Veteran cardiologist, dead at 76, remembered for his kindness and devotion

Share on Twitter Share on Facebook Share on Linkedin
Asher Kimchi, MD. Image courtesy of Cedars-Sinai.
Asher Kimchi, MD, a veteran cardiologist with Cedars-Sinai Medical Center in Los Angeles, died on Oct. 7. His friends and colleagues shared loving tributes to his legacy. 
READ MORE >

Medtronic cardiac lead the first to receive FDA approval for conduction system pacing

The company’s SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing.

READ MORE >
The Medtronic SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing, providing users with another option when treating patients for bradycardia. According to Medtronic, this marks the first time the FDA has approved a device for this indication.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic cardiac lead the first to receive FDA approval for conduction system pacing

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing, providing users with another option when treating patients for bradycardia. According to Medtronic, this marks the first time the FDA has approved a device for this indication.
The company’s SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing.
READ MORE >

In Case You Missed It

New-onset AFib, linked to worse outcomes and higher healthcare costs, seen in 3.5% of TEER patients

Patients who developed new-onset AFib tended to be sicker than those who did not. 

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

New-onset AFib, linked to worse outcomes and higher healthcare costs, seen in 3.5% of TEER patients

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
Patients who developed new-onset AFib tended to be sicker than those who did not. 
READ MORE >

In Other News

CDC reports early flu season

The 2022-2023 flu season is off to an early start, according to the Centers for Disease Control and Prevention (CDC), which noted there are increases happening in most of the country despite relatively low activity overall.

READ MORE >
flu_covid_sick.jpg
Share on Twitter Share on Facebook Share on Linkedin

CDC reports early flu season

Share on Twitter Share on Facebook Share on Linkedin
flu_covid_sick.jpg
The 2022-2023 flu season is off to an early start, according to the Centers for Disease Control and Prevention (CDC), which noted there are increases happening in most of the country despite relatively low activity overall.
READ MORE >

What most hospital ranking systems are missing

Hospitals have been nationally ranked by popular media sources such as U.S. World News & Report for decades, but the quality measures used to determine these lists may be missing one key domain––health equity.

READ MORE >
Hospital finance, Despite improving margins, hospitals face a long road to recovery from the COVID pandemic
Share on Twitter Share on Facebook Share on Linkedin

What most hospital ranking systems are missing

Share on Twitter Share on Facebook Share on Linkedin
Hospital finance, Despite improving margins, hospitals face a long road to recovery from the COVID pandemic
Hospitals have been nationally ranked by popular media sources such as U.S. World News & Report for decades, but the quality measures used to determine these lists may be missing one key domain––health equity.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme